PharmaTimes Magazine

PharmaTimes is the UK's leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.

Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.

You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.

View latest issue

View our archive

Digital edition sponsored by

Magazine highlights

View more from the latest edition

Diversity through development

How tech is enabling a more representative future for pharma

MAGAZINE EXCLUSIVE

Supporting the new healthcare normal

The healthcare industry has successfully brought effective vaccines to market despite massive disruption from COVID-19. But with global supply chains still stretched, what are the priorities for supply chain players as we move towards a ‘new normal’?

MAGAZINE EXCLUSIVE

A little less conversation, a little more action

Sustainability commitments alone won’t stop the climate crisis

Six lessons for medical congresses

Medical congresses can learn important lessons from how consumer brands have adapted to a COVID world

Smart People: Juliet Bauer

PharmaTimes talks to Juliet Bauer about her role as MD of Livi UK and the digital healthcare landscape

The patent waiver debate

In recent months an intense debate has arisen about a potential waiving of patent rights on COVID vaccines. This article looks at the background to this debate, the relevance of patent rights to the COVID vaccines and the various issues raised by the different protagonists.